IGF Oncology Anti-Cancer Drugs

Dr. Hugh McTavish, Company Founder, President, and CEO of IGF Oncology, a biotech company developing targeted anti-cancer drugs, talks about their lead drug IGF-MTX, that targets the deadly blood cancer MDS (Myelodysplastic syndromes), and is currently in clinical trials at the Mayo Clinic.

Read More

Clinical Stage Formulation to Treat Herpes Simplex 1 and 2

More than 9 Million people in the US suffer 6 or greater Herpes Simplex 1 and 2 (herpes labialis) outbreaks every year with no existing medications indicated for the prevention of additional occurrences.

In this interview, Dr. Hugh McTavish, Company Founder, President, and CEO of Squarex, LLC, a  clinical-stage pharmaceutical company, talks about the company developing a topical formulation for the prevention of recurrent cold sores (herpes labialis) and other infections caused by Herpes Simplex Virus 1 or Virus 2.

Read More

Raising Awareness of Postmenopausal Osteoporosis

Dr. Mary Oates, a specialist in the diagnosis and treatment of osteoporosis, discusses the importance of raising awareness of postmenopausal osteoporosis and its connection to fracture. She also talks about how to identify the warning signs and discuss a prescription treatment option that may help.

Read More

Surviving Pancreatic Cancer and Embracing Life

Pancreatic cancer survivor Joel Evans has beaten the odds and now he is on a mission to help others. In his brief, motivational memoir, SURVIVING CANCER AND EMBRACING LIFE: My Personal Journey, Evans shares his journey from the first phone call with the doctor, to today, where he’s created a website and blog to support others facing a devastating diagnosis.

Read More

GOBOLDLY “Together” Campaign

Dr. Mike Ybarra, board-certified emergency physician and Vice President of Medical Affairs and Strategic Alliances at PhRMA, discusses a new national series called Together that features patients and industry scientists who are behind the development of treatments and cures for complex and devastating conditions.  

Read More